Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer
Author:
Funder
CIHR
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference68 articles.
1. Metastatic triple-negative breast cancer;Rakha;Clin. Oncol.,2011
2. Triple-negative breast cancer: disease entity or title of convenience?;Carey;Nat. Rev. Clin. Oncol.,2010
3. Triple-negative breast cancers: a view from 10,000 feet;Ray;Cancer J.,2010
4. Canadian Cancer Society;Canadian Cancer Statistics,2014
5. Standard of care and promising new agents for triple negative metastatic breast cancer;Mancini;Cancer,2014
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial;Gynecologic Oncology;2024-02
2. Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy;JAMA Surgery;2023-11-01
3. Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells;Frontiers in Cell and Developmental Biology;2023-10-26
4. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells;International Journal of Hyperthermia;2023-10-23
5. Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer;Oral Oncology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3